Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Second Sight (EYES)

Second Sight (EYES)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 80,788
  • Shares Outstanding, K 39,409
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,920 K
  • 60-Month Beta 2.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.17
Trade EYES with:

Options Overview Details

View History
  • Implied Volatility 112.35% ( +11.19%)
  • Historical Volatility 69.39%
  • IV Percentile 29%
  • IV Rank 7.08%
  • IV High 513.35% on 03/02/22
  • IV Low 81.80% on 08/26/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 54
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 4,233
  • Open Int (30-Day) 4,197

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.77 +16.38%
on 08/01/22
2.40 -14.16%
on 07/18/22
+0.02 (+0.98%)
since 07/11/22
3-Month
1.40 +47.14%
on 05/12/22
2.70 -23.70%
on 06/06/22
+0.49 (+31.21%)
since 05/11/22
52-Week
1.14 +80.70%
on 02/24/22
4.24 -51.42%
on 08/31/21
-1.72 (-45.50%)
since 08/11/21

Most Recent Stories

More News
Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful...

EYES : 2.05 (-0.49%)
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial form of useful...

EYES : 2.05 (-0.49%)
Interesting EYES Call Options For November 18th

Investors in Second Sight Medical Products Inc saw new options become available this week, for the November 18th expiration. One of the key inputs that goes into the price an option buyer is willing...

EYES : 2.05 (-0.49%)
Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D.,...

EYES : 2.05 (-0.49%)
EYES Stock Investigation: Halper Sadeh LLP Is Investigating Whether the Merger of Second Sight Medical Products, Inc. Is Fair to Shareholders

Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Second Sight Medical Products, Inc. (NASDAQ: EYES) and Nano Precision Medical, Inc. is fair to Second Sight shareholders....

EYES : 2.05 (-0.49%)
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that they have entered into a definitive agreement...

EYES : 2.05 (-0.49%)
Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful...

EYES : 2.05 (-0.49%)
Second Sight Medical Products Announces Closing of Public Offering

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful...

EYES : 2.05 (-0.49%)
Second Sight Medical Products Announces Pricing of Public Offering

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful...

EYES : 2.05 (-0.49%)
Second Sight Medical Products Announces Proposed Public Offering of Common Stock

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”) a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful...

EYES : 2.05 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations,...

See More

Key Turning Points

3rd Resistance Point 2.19
2nd Resistance Point 2.13
1st Resistance Point 2.09
Last Price 2.05
1st Support Level 1.99
2nd Support Level 1.93
3rd Support Level 1.89

See More

52-Week High 4.24
Fibonacci 61.8% 3.06
Fibonacci 50% 2.69
Fibonacci 38.2% 2.32
Last Price 2.05
52-Week Low 1.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar